FANCF and ovarian cancer: Monoubiquitination of FANCD2 is a measure of the activity of this DNA damage repair pathway, and disruption of this pathway in ovarian cancer results from the hypermethylation and silencing of one of the FA genes, FANCF, leading to increased sensitivity to the DNA-damaging agent cisplatin [144].